What’s the current market cap for PACS Group stock?

PACS Group (PACS) has a market cap of $5.7bn as of June 17, 2026.

What is the P/E ratio for PACS Group stock?

The price to earnings (P/E) ratio for PACS Group (PACS) stock is 23.06 as of June 17, 2026.

Does PACS Group stock pay dividends?

No, PACS Group (PACS) stock does not pay dividends to its shareholders as of June 17, 2026.

When is the next PACS Group dividend payment date?

PACS Group (PACS) stock does not pay dividends to its shareholders.

What is the beta indicator for PACS Group?

PACS Group (PACS) has a beta rating of -0.03. This means that it has an inverse relation to market volatility.

Buy PACS Group stock | $PACS Share Price

About PACS Group

PACS Group Inc is a post-acute healthcare company mainly focused on delivering skilled nursing care through a portfolio of independently operated facilities. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after getting discharged from the hospital. It also provides senior care, assisted living, and independent living options in some of the communities. The company has one reportable segment.

Ticker

$PACS

Sector

Health

Primary listing

NYSE

Employees

47,455

Headquarters

Salt Lake City, United States

Website

pacs.com

PACS Group Metrics

BasicAdvanced

$5.7bn

23.06

$1.56

-0.03

-

What the Analysts think about PACS Group

Analyst ratings (Buy, Hold, Sell) for PACS Group stock.

Bulls say / Bears say

In Q1 2026, PACS delivered a 75% year-over-year surge in adjusted EBITDA to $170.4 million on revenue of $1.42 billion and raised full-year 2026 adjusted EBITDA guidance to $605 million–$625 million, up from $555 million–$575 million, underscoring robust operational performance and margin expansion. (Business Wire)

Occupancy improved to 90.9% in Q1 2026 from 89.6% a year earlier, and the skilled mix increased, reflecting higher bed utilization and improved revenue potential. (PACS Group 8-K)

In January 2026, PACS acquired operations of three post-acute facilities and the real estate of four facilities in Alaska and Idaho, adding 230 beds and enhancing its strategic presence in key markets. (NASDAQ)

PACS has entered into multiple forbearance agreements and amendments to its Amended and Restated Credit Facility to waive technical defaults and maintain a liquidity requirement through June 30, 2026, highlighting potential covenant and leverage risks. (PACS Group 10-Q)

Net cash used in investing activities rose to $127.0 million in Q1 2026—up $110.5 million year-over-year driven by facility acquisitions—and net cash used in financing was $67.7 million, reflecting elevated capital deployment that may pressure liquidity. (PACS Group 10-Q)

Management cited dependency on third-party payor reimbursement, patient acuity mix, and uncertainty over state programs like California’s WQIP as key risks that could adversely impact revenue and EBITDA. (Business Wire)

Data summarised monthly by Lightyear AI. Last updated on 16 Jun 2026.

PACS Group Financial Performance

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37bn

-39.75%

Net income

$45bn

107.52%

Profit margin

37.65%

6.78%

PACS Group Earnings Performance

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

PACS Group News

AllArticlesVideos

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

About PACS Group

Ticker

Primary listing

Employees

PACS Group Metrics

Price and volume

Financial strength

Profitability

Management effectiveness

Valuation

Growth

What the Analysts think about PACS Group

Analyst Ratings

Bulls say / Bears say

PACS Group Financial Performance

Income Statement

PACS Group Earnings Performance

Earnings per share (EPS)

PACS Group News

Varist Announces AI-Scale Malware Detection for Healthcare and Medical Imaging

PACS Group Q1 Earnings Call Highlights

PACS Group, Inc. Reports First Quarter 2026 Results

Buy $PACS

Upcoming events

No upcoming events

Lightyear

Legal

Work with us

Bulls say / Bears say

PACS Group/$PACS

About PACS Group

Ticker

Primary listing

Employees

PACS Group Metrics

Price and volume

Financial strength

Profitability

Management effectiveness

Valuation

Growth

What the Analysts think about PACS Group

Analyst Ratings

Bulls say / Bears say

PACS Group Financial Performance

Income Statement

PACS Group Earnings Performance

Earnings per share (EPS)

PACS Group News

Varist Announces AI-Scale Malware Detection for Healthcare and Medical Imaging

PACS Group Q1 Earnings Call Highlights

PACS Group, Inc. Reports First Quarter 2026 Results

Buy $PACS

Upcoming events

No upcoming events

What’s the current market cap for PACS Group stock?

What is the P/E ratio for PACS Group stock?

Does PACS Group stock pay dividends?

When is the next PACS Group dividend payment date?

What is the beta indicator for PACS Group?

Bulls say / Bears say